Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Novel hemoregulatory compounds from SKB

July 10, 1997

Update on Pfizer/Ligand treatments for osteoporosis and breast cancer

July 9, 1997

MGI Pharma launches INFeD for anemia in cancer patients

July 9, 1997

Oxford GlycoSciences licenses compound for treatment of glycolipid storage disorders

July 9, 1997

Didronel PMO now available for expanded use in the U.K.

July 9, 1997

Lilly reports new salt of PKC inhibitor with improved pharmaceutical properties

July 9, 1997

SmithKline Beecham focuses on hemoregulatory compounds

July 9, 1997

Senetek seeks Danish approval of erectile dysfunction therapy

July 8, 1997

Bioisosteres of sulfonylureas prepared by Belgian investigators

July 8, 1997

SmithKline Beecham reports novel hemoregulatory compounds

July 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...